Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia

Clinical trial NCT00103844 · COMPLETED

Trial details

NCT number: NCT00103844
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia Philadelphia-Positive Myeloid Leukemia

Start date: 2005-02-01
Primary completion: 2006-08-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.